MetaCap

Cullinan Therapeutics Statistics

NASDAQ: CGEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.89-0.18 (-1.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cullinan Therapeutics by the numbers

Cullinan Therapeutics has a market capitalization of $577.1 million based on 64.92M shares outstanding. With trailing EPS of $-3.09, Cullinan Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 39.3% below its 50-day average and 43.5% below its 200-day average.

Average daily trading volume is 997.14K shares, or about $8.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CGEM valuation vs. peer median

CGEM compared with the median of 8 peer companies
MetricCGEMPeer medianDifference
Market cap$577.15M$576.14M+0%
Avg. volume997.14K487.75K+104%

Peer median across 8 companies: SRZN, FDMT, ENTX, DBVT, IAM, ETRA, VALN, ATTO.

Valuation

Price and trading

Previous close
9.07
Open
8.84
Day range
8.80 – 9.43
52-week range
8.47 – 23.19
52-week change
-6.12%
Beta
—
Volume
1.01M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
577.15M
Forward Pe
-3.85
Eps
-3.09
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
23.19
Week52 Low
8.47
Avg Volume
997.14K
Shares Outstanding
64.92M
Ma50
14.65
Ma200
15.74
Earnings Date
Nov 10, 2026
Pct From52w High
-61.66%
Pct From52w Low
4.96%

Related